A Study on Uric Acid Levels in Type 2 Diabetes Mellitus with Chronic Kidney Disease
Keywords:
Uric Acid Levels, Type 2 Diabetes Mellitus, Chronic Kidney DiseaseAbstract
Background: The classification of stages of CKD is based on the level of kidney function measured by GFR, stage 1 represents kidney damage with normal or elevated GFR and stage 5 represents a GFR of less than 15 ml/min or who require treatment with dialysis. In recent times a new equation the Chronic Kidney Disease-Epidemiological Collaboration (CKD-EPI) has been introduced. The CKD-EPI equation has lower bias, especially at an estimated GFR greater than 60 mL/min per 1.73 m2; however, precision remains limited. Subjects and Methods: The study was undertaken in the Department Of General Medicine,and a total 64 CKD patients are included in study who fulfilled the inclusion and exclusion criteria. These cases taken are not overlapped with other postgraduate students. The patients were randomly divided into two groups according group chosen by time of enrollment. Results: The Study reveals that, there was no statistical significant difference of mean serum uric acid among smokers and non-smokers in Type 2 diabetes mellitus with CKD(P>0.05). Conclusion: Study reveals that, there was no statistical significant difference of mean serum uric acid among alcoholic and non-alcoholic cases in Type 2 diabetes mellitus with CKD(P>0.05).
Downloads
References
1. Eriksson J, Kohvakka A. 1995. Magnesium and ascorbic acid supplementation in DM. Ann NutrMetab 39:217-223.
2. Dierckx N, Horvath G, Van Gils C, Vertommen J, Van de Vliet J, De Leeuw I, Manuel-y-Keenoy B. 2003.Oxidative stress status in patients with diabetes mellitus:relationship to diet. European Journal of Clinical Nutrition 57:999–1008).
3. American Diabetes Association. Standards of medical care in diabetes: 2011. Diabetes Care 2011;34(Suppl. 1):S11–S61. 4. Eggers PW. Has the incidence of end-stage renal disease in the USA and other countries stabilized? CurrOpinNephrolHypertens 2011;20:241–245.
5. Brenner BM, Parving H-H, Mauer M, Ritz E. Diabetic nephropathy. In The Kidney.Brenner BM, Ed. Philadelphia,WBSaunders,2004, p. 1777–1818 . .
6. Hyperuricemia and the progression of chronic kidney disease: is uric acid a marker or an independent risk factor? Nashar K, Fried LF.Adv Chronic Kidney Dis. 2012 Nov; 19(6):386-9
7. Vahid Ansari, Mehryar Zargari, Atieh Makhlogh, Shivasaddat Mirabedini, Samineh Motallebi. 2015.Association of Uric Acid with Antioxidant Capacity of Plasma in Patients with Type 2 Diabetic Nephropathy. Res Mol Med 3(4):23-27.
8. Antón FM, GarcíaPuig J, Ramos T, González P, Ordás J. Sex differences in uric acidmetabolism in adults: evidence for a lack of influence of estradiol-17 beta (E2) on the renal handling of urate. Metabolism. 1986 Apr; 35(4): 343-8.
9. Iseki K, Ikemiya Y, Inoue T, Iseki C, Kinjo K, Takishita S. Significance of yperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis 2004;44:642–650.
10. Mark A. Reynolds, Donald K. Ingram, Richard G. Cutler. Serum uric acid: Correlation with behavioral, metabolic, age, and lifespan parameters among inbred mice. AGE: October 1984, Volume 7, Issue 4, pp 93-99.
